PRTA News Alert Prothena Corporation Plc (PRTA) 18.15 12/13/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Prothena Corporation Plc (PRTA) 18.15 $PRTA

Commit To Purchase Prothena Corp At $17.50, Earn 33.1% Annualized Using Options
at The Street - Fri Dec 12, 10:45AM CST
Investors considering a purchase of Prothena Corp plc shares, but tentative about paying the going market price of $17.97/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put...
PRTA: 18.15 (-0.34)

First patient enrolled in Acorda Phase 3 PD trial
Seeking Alpha - at Seeking Alpha - Wed Dec 10, 7:06AM CST

IPXL: 31.16 (-0.74), ADMS: 13.97 (-0.42), TEVA: 55.92 (-0.92), ACOR: 38.70 (+0.06), PRTA: 18.15 (-0.34), NDRM: 7.19 (-0.17)

Prothena to Present at the Oppenheimer 25th Annual Healthcare Conference in New York
GlobeNewswire - Mon Dec 08, 4:11PM CST
Prothena Corporation plc (Nasdaq RTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel antibodies for the potential treatment of diseases that involve amyloid or cell adhesion, announced that Tran Nguyen, the Company's Chief Financial Officer, will be presenting at the Oppenheimer 25 Annual Healthcare Conference on Thursday, December 11, 2014, at 10:55 AM EST. The conference will be held at the Crowne Plaza Hotel in New York.
PRTA: 18.15 (-0.34)

Prothena Corporation (PRTA) Falls: Stock Goes Down 5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Dec 04, 7:37AM CST
Shares of Prothena Corporation (PRTA) fell over 5% on the day. This continues the most recent downtrend for PRTA, as the stock is down over 9% since Nov 28. Although this slump was obviously disappointing the company has seen positive revisions and its current year loss consensus has narrowed over the past few weeks.
BIIB: 344.49 (+2.16), ANIP: 54.28 (+2.33), PRTA: 18.15 (-0.34), AFFX: 8.94 (-0.36)

Prothena Initiates NEOD001 Global Phase 3 Registrational Trial Based on Positive Results in Ongoing Phase 1/2 Study of NEOD001 in Patients With AL Amyloidosis
Thomson Reuters ONE - Tue Dec 02, 3:05PM CST
- New and Updated Results Show 50% Response Rate in 14 Cardiac-Evaluable Patients
PRTA: 18.15 (-0.34)

Why You Shouldn't Bet Against Prothena Corporation (PRTA) Stock - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Dec 01, 7:43AM CST
Prothena Corporation might be an intriguing choice for investors as it is seeing solid earnings estimate revision activity and is in great company from a Zacks Industry Rank perspective
PRTA: 18.15 (-0.34)

Prothena's Management Presents at 2014 Credit Suisse Healthcare Conference (Transcript)
SA Transcripts - at Seeking Alpha - Tue Nov 11, 2:16PM CST

PRTA: 18.15 (-0.34)

Prothena Reports Third Quarter 2014 Financial Results and R&D Progress
GlobeNewswire - Mon Nov 03, 5:29PM CST
-- Net cash used in operating activities was $12.3 million in the third quarter, while quarter-end cash position of $306.2 million provides solid runway for advancement of multiple programs
PRTA: 18.15 (-0.34)

Prothena beats by $0.12, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 4:06PM CST

PRTA: 18.15 (-0.34)

Genervon ALS drug shows encouraging results
Seeking Alpha - at Seeking Alpha - Mon Oct 20, 7:27AM CDT

BIIB: 344.49 (+2.16), MNOV: 3.60 (+0.18), CHTP: 6.52 (-0.03), ADMS: 13.97 (-0.42), ACOR: 38.70 (+0.06), BCLI: 2.90 (-0.06), BSX: 13.00 (+0.11), IPXL: 31.16 (-0.74), AVNR: 16.95 (-0.02), ACAD: 32.53 (-0.10), CVTS: (), MRK: 57.72 (-1.62), TEVA: 55.92 (-0.92), PRTA: 18.15 (-0.34), PRAN: 1.86 (-0.05), FOLD: 8.15 (+0.18), CUR: 2.58 (-0.09)

The Next Biotech Buyout Stock
Motley Fool Staff - Motley Fool - Fri Oct 10, 7:15AM CDT
Biotech stocks are notoriously volatile, making them best suited for only the most risk-tolerant investors. But for those willing to take the risk, biotech companies can often make a big splash; particularly when a bigger fish gobbles them up....
JNJ: 104.43 (-2.29), PTLA: 28.27 (-0.27), PFE: 30.95 (-0.70), BMY: 58.75 (-0.93), PRTA: 18.15 (-0.34), PBYI: 196.34 (-7.66)

Why Prothena Corporation (PRTA) Stock Might be a Great Pick - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Sep 25, 7:43AM CDT
Prothena Corporation belongs to the Medical and Biomedical industry, is a decent pick as it witnessed solid earnings estimate revision activity with a favorable Zacks Industry Rank.
PRTA: 18.15 (-0.34)

Zacks Rank #1 Additions for Friday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Sep 05, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
KMX: 58.30 (-1.21), CRUS: 18.84 (-0.12), MEI: 34.66 (-0.99), PRTA: 18.15 (-0.34), GPX: 31.40 (-0.18)

Prothena Announces Presentation at Federation of European Physiological Societies 2014 Congress
GlobeNewswire - Tue Aug 26, 3:08PM CDT
-- Data to be Presented by Dr. Timo Siepmann on the Discovery of a Potential New Non-Invasive Biomarker for Parkinson's Disease
PRTA: 18.15 (-0.34)

Dr. Dale Schenk to Discuss Parkinson's Disease at 2014 Rejuvenation Biotechnology Conference
Thomson Reuters ONE - Mon Aug 18, 3:05PM CDT
DUBLIN, Ireland, Aug. 18, 2014 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq RTA), a clinical stage biotechnology company focused on the discovery, development and commercialization of novel antibodies for the potential treatment of diseases that involve protein misfolding or cell adhesion, today announced that Dale Schenk, PhD, the Company's President and Chief Executive Officer, will be presenting at the 2014 Rejuvenation Biotechnology Conference, a SENS Research Foundation Conference, on Friday, August 22, 2014.
PRTA: 18.15 (-0.34)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Amdocs Shares Plunge Over T-Mobile Legal Clash

Updated Category News Views 38

Nothing like waking up to the smell of lawsuits, huh? That's what Amdocs Limited (NASDAQ: DOX) investors were hit with on the morning of November 4, 2026. Watching nearly a third of your stock's value evaporate overnight—ouch. This all happened because of a classic corporate slugfest with none other than T-Mobile. Now, they're slugging it out over a supposedly...

Continue Reading
Pyramid Teams with Bell Federal for NASA SEWP VI

Updated Category News Views 137

A New Federal Contract Partnership Takes Flight If you're watching government tech contracts like a hawk, there's a fresh collaboration to note—Pyramid Systems is hitching up with Bell Federal Systems to deliver AIR-Quire solutions via NASA's Solutions for Enterprise-Wide Procurement VI, known as SEWP VI. With this partnership, these two outfits aim to streamline how...

Continue Reading
AI Shift: From Tech Marvels to Practical Uses

Updated Category News Views 135

A New Chapter in the AI Narrative Take a seat, folks, because we're watching AI swing from showy tech to something as plain as plumbing infrastructure. Imagine models that once cost bundles per token now going for peanuts. We're talking a nosedive from $37.50 to a mere 18 cents. It’s a seismic shift, steering the conversation from 'Are they the best models?' to 'How...

Continue Reading
Zillow Eases the FHA Down Payment Burden

Updated Category News Views 22

A New Financial Lifeline for Homebuyers In a market where finding a foothold in the housing game feels like scaling Everest without ropes, Zillow Home Loans has tossed a lifeline to potential homeowners. Their latest move might just be what many house hunters needed to hear—offering a hand where it’s been missing for years: down payment assistance for FHA loans. The...

Continue Reading
WellNet Embraces Voice AI for Provider Calls

Updated Category News Views 141

Ever met a TPA grappling over their provider call costs like a crusty sailor with a rusted anchor? Welcome to WellNet Healthcare, folks. They've tapped EHVAhealth's conversational voice AI to take a solid swing at automating those burdensome provider calls. They're no stranger to the chaos of managing member eligibility and benefits verification, and this move might just...

Continue Reading
Laser Weapon Market to Double: Military Demand Surges

Updated Category News Views 108

Pew Pew: Lasers Are the Future of Defense Forget lightsabers, we've got something even flashier—a market that's going to double in worth by 2035. High-energy laser weapons are coming in hot, growing from USD 2.17 billion in 2026 to an estimated USD 4.54 billion by the end of 2035. That's no small potatoes! What's Driving This Beam Dream? The military is all about upping...

Continue Reading
Ampace Shifts Focus to Reliability in Two-Wheeler Batteries

Updated Category News Views 88

Here's a Shift: Reliability Over Specs Alright, folks, buckle up because Ampace is shaking things up at EICMA Milan this year. While some are still yammering on about juicing up specs, Ampace is talking reliability. It's a bold move in the fast-evolving two-wheeler battery market, where everyone's been obsessed with horsepower and max speeds. The landscape's shifting...

Continue Reading
Vehicle Reliability Hinges on Design and Maintenance

Updated Category News Views 51

Why Some Cars Age Like Fine Wine—and Some Don't Here’s the thing—cars aren’t all made equal, and anybody who's tinkered around under the hood for a few years long knows that some vehicles just can’t hold it together as time marches on. Now, this ain't rocket science, but the truth is wrapped up in the complexity of designs and those pesky little maintenance...

Continue Reading
Belay Diagnostics Clinches Second Palantir Title

Updated Category News Views 45

Innovation in Liquid Biopsy Lands Belay Another Win Another round of applause is due for Belay Diagnostics, the brainy bunch in molecular diagnostics focused on CSF liquid biopsy for CNS cancers. This Chicago-based powerhouse clinched its second consecutive victory at the Palantir Foundry Buildcamp competition. The team must be on some winning streak, as they're not just...

Continue Reading
2027 Shanghai Boat Show: 30 Years of Nautical Ambition

Updated Category News Views 126

The 2027 Shanghai Boat Show: A Decades-Spanning Legacy You ever catch the wave just right, feeling that rush when the tide’s in your favor? That’s the buzz around the 2027 China (Shanghai) International Boat Show—better known as CIBS—celebrating its 30th anniversary. In this boat show shindig, we're looking at a whole host of innovations that could power up this...

Continue Reading

Top 5 Most Recently Viewed Articles

Visa Inc Sees Strong Financial Gains and Anticipates Growth Plans

Updated Category News Views 225

Visa Inc Reports Strong Financial Growth Visa Inc (NYSE: V) has recently shared its fiscal fourth quarter and full year 2024 earnings, demonstrating a robust financial performance characterized by substantial increases in net revenue and earnings per share (EPS). Notably, the company reported an impressive 8% growth in overall payments volume and a 13% increase in...

Continue Reading
Jackson State University Launches Cybersecurity Lab with $2M Grant

Updated Category News Views 79

Jackson State University Receives Grant for Cybersecurity Lab Jackson State University (JSU) is set to enhance its academic offerings with the introduction of a Critical Power Grid Network Security Lab, thanks to a generous $2 million grant from the Entergy Charitable Foundation. This partnership marks a significant milestone for JSU as it reinforces its commitment to...

Continue Reading
Innovative Partnership Between Novartis and NFL for Health

Updated Category News Views 298

Novartis Partners with NFL for Health and Wellness Initiatives In an exciting collaboration, Novartis, a prominent leader in innovative medicines, has joined forces with the National Football League (NFL) as the first-ever corporate pharmaceutical partner. This groundbreaking agreement is set to leverage the fervent passion of football fans to encourage a commitment to...

Continue Reading
S&P 500 Ends Strong First Half Despite Friday Dip

Updated Category Markets Views 298

S&P 500 Closes Lower, Ending Strong First Half of 2024 At 5,460.48, the S&P 500 ended Friday down 0.41%. Though the index fell, it had a great first half of 2024, rising 14.5%. Investors were pleased to see slowing inflation in the economic data released on Friday. Before retreating, the index had earlier in the session hit a new intraday high. Equally falling, the Nasdaq...

Continue Reading
Atlanta's Copper Sky Design Triumphs as HGTV's Top Designer

Updated Category News Views 239

Copper Sky Design + Remodel: A Celebration of Creativity In a remarkable achievement, Copper Sky Design + Remodel has garnered acclaim as HGTV's Overall Winner in the prestigious "Designer of the Year" competition. This talented Atlanta-based renovation firm has once again demonstrated its outstanding skill in creating beautiful and functional spaces. Judging Panel and...

Continue Reading